A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Completed · Phase 2 · NCT06176768
Conditions: Plaque Psoriasis
At a glance
- Research payments reported, 2025
- $201,747
- U.S. investigators named
- 11
- Sites paid
- 12
- Planned or actual enrollment
- 33
About the trial
- Sponsor
- Eli Lilly and Company
- Tested
- LY3972406 (drug), Placebo (drug)
- Dates
- Started 2023-12-06; completion 2025-05-06
- Results posted
- Yes
The main purpose of this study is to determine the efficacy and safety of LY3972406 in adult participants with moderate-to-severe plaque psoriasis.
From ClinicalTrials.gov, last updated 2025-10-15. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Eli Lilly and Company reported $201,747 in research payments for this study in 2025 (20 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Howard L. Sofen, M.D. Dermatology · Los Angeles, CA
- Paul S. Yamauchi, M.D., PHD Dermatology · Santa Monica, CA
- Malisa Agard, M.D. Internal Medicine · Orlando, FL
- Javier Alonso-llamazares, M.D.PHD. Dermatology · Coral Gables, FL
- Christine A. Yuengel-bienenfeld, M.D. Dermatology · Winston-salem, NC
- Alexander Doctoroff, D.O. Dermatology · Clark, NJ
- David J. Goldberg, M.D Mohs Surgery · Hackensack, NJ
- Michelle C. Chambers, M.D. Dermatology · Columbus, OH
- Stephen M. Schleicher, M.D. Dermatology · Sugarloaf, PA
- Megan P. Couvillion, MD Dermatology · Houston, TX
- Stephen K. Tyring, MD PHD Dermatology · Webster, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Conquest Research LLC $75,182
- Remington-Davis, Inc. $36,986
- Driven Research LLC $29,750
- Austin Institute for Clinical Research Inc $23,703
- Metropolitan Dermatology Clark $9,438
- Schweiger Dermatology PC Research Division $8,568
- Center for Clinical Studies LTD LLP $5,704
- Dermatology Research Associates Inc $5,411
- Piedmont Medical Research Associates Inc $4,000
- Best Skin Research LLC $2,700
- Rheumatology Center of Houston $175
- Dermatology Institute and Skin Care $130
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.